| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Canadian national guideline on the neoadjuvant treatment of invasive breast cancer, including patient assessment, systemic therapy, and local management principles
|
Gandhi, Sonal
|
|
|
193 |
1 |
p. 1-20
|
artikel
|
| 2 |
Clinicopathological characteristics and prognostic analysis of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ (DCIS) and DCIS with microinvasion (DCIS-Mi) of the breast
|
Jia, Huiqing
|
|
|
193 |
1 |
p. 111-120
|
artikel
|
| 3 |
Comment on “Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis”
|
Nie, Weihong
|
|
|
193 |
1 |
p. 237-238
|
artikel
|
| 4 |
Common founder BRCA2 pathogenic variants and breast cancer characteristics in Ethiopian Jews
|
Lieberman, S.
|
|
|
193 |
1 |
p. 217-224
|
artikel
|
| 5 |
Concordance between core needle biopsy and surgical excision for breast cancer tumor grade and biomarkers
|
Shanmugalingam, Aswin
|
|
|
193 |
1 |
p. 151-159
|
artikel
|
| 6 |
Emerging strategies for TNBC with early clinical data: new chemoimmunotherapy strategies
|
Hall, Peter E.
|
|
|
193 |
1 |
p. 21-35
|
artikel
|
| 7 |
Endocrine therapy initiation among women with stage I–III invasive, hormone receptor-positive breast cancer from 2001–2016
|
Bowles, Erin J. Aiello
|
|
|
193 |
1 |
p. 203-216
|
artikel
|
| 8 |
Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT
|
Zhu, Yihui
|
|
|
193 |
1 |
p. 65-81
|
artikel
|
| 9 |
High RAD51 gene expression is associated with aggressive biology and with poor survival in breast cancer
|
Wu, Rongrong
|
|
|
193 |
1 |
p. 49-63
|
artikel
|
| 10 |
Multi-center evaluation of artificial intelligent imaging and clinical models for predicting neoadjuvant chemotherapy response in breast cancer
|
Qi, Tan Hong
|
|
|
193 |
1 |
p. 121-138
|
artikel
|
| 11 |
Population-based estimates of overtreatment with adjuvant systemic therapy in early breast cancer patients with data from the Netherlands and the USA
|
Ragusi, M. A. A.
|
|
|
193 |
1 |
p. 161-173
|
artikel
|
| 12 |
Post-diagnostic beta blocker use and breast cancer-specific mortality: a population-based cohort study
|
Scott, Oliver William
|
|
|
193 |
1 |
p. 225-235
|
artikel
|
| 13 |
Radiotherapy, chemotherapy, and heart disease
|
Sioka, Chrissa
|
|
|
193 |
1 |
p. 239-240
|
artikel
|
| 14 |
Real-world clinical outcomes of patients with BRCA-mutated, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: a CancerLinQ® study
|
Miller, Robert S.
|
|
|
193 |
1 |
p. 83-94
|
artikel
|
| 15 |
Ribociclib plus letrozole in male patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: subgroup analysis of the phase IIIb CompLEEment-1 trial
|
Campone, Mario
|
|
|
193 |
1 |
p. 95-103
|
artikel
|
| 16 |
Sexual activity and functioning in long-term breast cancer survivors; exploring associated factors in a nationwide survey
|
Smedsland, Solveig K.
|
|
|
193 |
1 |
p. 139-149
|
artikel
|
| 17 |
The association between meat and fish intake by preparation methods and breast cancer in the Carolina Breast Cancer Study (CBCS)
|
Omofuma, Omonefe O.
|
|
|
193 |
1 |
p. 187-201
|
artikel
|
| 18 |
Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol
|
van Loevezijn, Ariane A.
|
|
|
193 |
1 |
p. 37-48
|
artikel
|
| 19 |
Trends in surgery and adjuvant treatment for early-stage breast cancer: a population-based study in Queensland, Australia
|
Youl, Philippa
|
|
|
193 |
1 |
p. 175-185
|
artikel
|
| 20 |
Validation sentinel lymph node biopsy study in cN0 axilla using low-cost dual dye technique: potential solution for resource poor settings
|
Chavda, Jayesh
|
|
|
193 |
1 |
p. 105-110
|
artikel
|
Tijdschrift beschrijving